Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LAP3 | P28838 | 3/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | ANPEP | P15144 | 3/20 | 0.30 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL313933 | 0.87 | — | — | |
| SCHEMBL7889185 | 0.87 | — | — | |
| SCHEMBL7883560 | 0.87 | — | — | |
| Phosphoric Acid SCHEMBL5964269 | 0.80 | LAP3 (0.42) | LAP3TSHRANPEPERAP1 | |
| Nitrous Acid SCHEMBL7088089 | 0.80 | — | — | |
| Phosphoric Acid SCHEMBL5964228 | 0.75 | CA2 (0.35) | LAP3TSHRANPEPERAP1 | |
| Phosphoric Acid SCHEMBL156419 | 0.75 | CA2 (0.35) | LAP3TSHRANPEPERAP1 | |
| Phosphoric Acid SCHEMBL18486680 | 0.75 | CA2 (0.35) | LAP3TSHRANPEPERAP1 | |
| SCHEMBL8274625 | 0.75 | — | — | |
| SCHEMBL2030735 | 0.75 | TSHR (0.50) | TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220356497-A1 | COMPOSITIONS AND METHODS FOR SYNTHESIS OF TERPENOIDS | ZYMERGEN INC. | 2022-11-10 | — | — | US | disclosed |
| US-20210395763-A1 | IMPROVED PRODUCTION OF TERPENOIDS USING ENZYMES ANCHORED TO LIPID DROPLET SURFACE PROTEINS | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2021-12-23 | — | — | US | disclosed |
| EP-3833754-A2 | IMPROVED PRODUCTION OF TERPENOIDS USING ENZYMES ANCHORED TO LIPID DROPLET SURFACE PROTEINS | Board of Trustees of Michigan State University (US) | 2021-06-16 | — | — | EP | disclosed |
| WO-2020264400-A2 | COMPOSITIONS AND METHODS FOR SYNTHESIS OF TERPENOIDS | ZYMERGEN INC. (US) | 2020-12-30 | — | — | WO | disclosed |
| WO-2020033705-A2 | IMPROVED PRODUCTION OF TERPENOIDS USING ENZYMES ANCHORED TO LIPID DROPLET SURFACE PROTEINS | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2020-02-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210395763-A1 | IMPROVED PRODUCTION OF TERPENOIDS USING ENZYMES ANCHORED TO LIPID DROPLET SURFACE PROTEINS | FADS2, SCD, FADS1 | LAP3 1245/4885TSHR 3204/4885TDP1 2849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.